NeoGenomics, Inc. Other Noncash Income (Expense)
NeoGenomics, Inc. (NEO) reported Other Noncash Income (Expense) of -$1.71 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-24.
Discontinued › Cash Flow › Operating Activities
us-gaap:OtherNoncashIncomeExpense · last filed 2023-02-24
- NeoGenomics, Inc. other noncash income (expense) for fiscal 2022 was -$1.71M.
- NeoGenomics, Inc. other noncash income (expense) for fiscal 2021 was -$1.94M.
- NeoGenomics, Inc. other noncash income (expense) for fiscal 2020 was -$1.01M.
- NeoGenomics, Inc. other noncash income (expense) for fiscal 2019 was -$472.00K.
| Period end | Other Noncash Income (Expense) 12 month | Other Noncash Income (Expense) 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$1.71M 10-K · filed 2023-02-24 | |
| 2021-12-31 | -$1.94M 10-K · filed 2023-02-24 | -$2.55M 10-K · filed 2022-02-25 |
| 2020-12-31 | -$1.01M 10-K · filed 2023-02-24 | -$1.46M 10-K · filed 2021-02-25 |
| 2019-12-31 | -$472.00K 10-K · filed 2022-02-25 | |
| 2018-12-31 | -$404.00K 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |